Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time Consolidated revenue up 2.7% to EUR 890.1 million. Growth in high-margin ...
Opioid Withdrawal Treatment market Rising Trends, Demand and Future Scope 2025 to 2034 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback